Thrombophlebitis
This disease is a venous disease characterized by acute non-suppurative inflammation of the venous wall and thrombosis in the lumen. The main causes are slow blood flow and vortex formation, increased blood coagulability and vascular endothelial damage. Clinically, it is divided into superficial thrombophlebitis and deep vein thrombosis. It needs to be differentiated from venous edema and lymphedema. The main purpose of treating this disease is to localize thrombosis and inflammation; eliminate swelling, restore venous function as much as possible; and prevent the development of fatal pulmonary embolism.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Fever tenderness tenderness in the femoral triangle nodules inferior vena cava thrombosis -
Concurrent disease:
Related Drugs
Troxerutin Tablets
Indication: Used for occlusive syndrome, thrombophlebitis, capillary bleeding, etc.
Manufacturer:
Jilin Jiuyang Pharmaceutical Co., Ltd.
Antithrombotic Capsules
Manufacturer:
Zhengzhou Handu Pharmaceutical Group Co., Ltd.
Troxerutin
Indication: 1. It is suitable for hemiplegia, aphasia, pre-myocardial infarction syndrome, arteriosclerosis, central retinitis, thrombophlebitis, varicose veins, edema caused by increased vascular permeability, etc. caused by cerebral thrombosis and cerebral embolism; 2. It is suitable for hemiplegia, aphasia, arteriosclerosis, pre-infarction syndrome, thrombophlebitis, varicose veins, chronic venous insufficiency, central retinitis, diabetic retinitis, and edema caused by increased vascular permeability, etc. caused by cerebral thrombosis; 3. Clinical application shows that this product has a wide range of application and good efficacy, especially for the treatment of occlusive cerebrovascular disease.
Manufacturer:
Shanxi Tongji Pharmaceutical Co., Ltd.
Troxerutin
Indication: 1. It is suitable for hemiplegia, aphasia, pre-myocardial infarction syndrome, arteriosclerosis, central retinitis, thrombophlebitis, varicose veins, edema caused by increased vascular permeability, etc. caused by cerebral thrombosis and cerebral embolism; 2. It is suitable for hemiplegia, aphasia, arteriosclerosis, pre-infarction syndrome, thrombophlebitis, varicose veins, chronic venous insufficiency, central retinitis, diabetic retinitis, and edema caused by increased vascular permeability, etc. caused by cerebral thrombosis; 3. Clinical application shows that this product has a wide range of application and good efficacy, especially for the treatment of occlusive cerebrovascular disease.
Manufacturer:
Shanxi Jinhuahuixing Pharmaceutical. Co., Ltd.
Troxerutin Capsules
Indication: This product is used for occlusive syndrome, thrombophlebitis, capillary bleeding, etc.
Manufacturer:
China Resources Zizhu Pharmaceutical Co., Ltd.
Troxerutin Capsules
Indication: This product is used for occlusive syndrome, thrombophlebitis, capillary bleeding, etc.
Manufacturer:
Jilin Galaxy Pharmaceutical Co., Ltd.
Antithrombotic Capsules
Manufacturer:
Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd.
Related Ingredients
-
Troxerutin list
7085-55-4 -
β-D-Glucopyranoside, [3-hydroxy-3-(methoxycarbonyl)-1,5-dioxo-1,5-pentanediyl]bis(oxymethylene-4,1-phenylene) bis- list
1971915-61-3